Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 157,145 | 148,202 | 158,894 | 146,587 | 139,202 |
| Cost of Goods | 77,264 | 74,600 | 94,810 | 70,879 | 75,155 |
| Gross Profit | 79,881 | 73,602 | 64,084 | 75,708 | 64,047 |
| Operating Expenses | 64,262 | 69,462 | 72,816 | 67,313 | 62,923 |
| Operating Income | 15,883 | 4,740 | -7,922 | 9,274 | 1,279 |
| Other Income | 17,461 | 12,915 | 13,362 | 8,627 | 7,893 |
| Pre-tax Income | 33,344 | 17,655 | 5,440 | 17,901 | 9,172 |
| Income Tax | 13,136 | 9,108 | -4,593 | 10,987 | 1,907 |
| Net Income Continuous | 20,208 | 8,547 | 10,033 | 6,914 | 7,265 |
| Net Income | $20,208 | $8,547 | $10,033 | $6,914 | $7,265 |
| EPS Basic Total Ops | 0.54 | 0.23 | 0.27 | 0.19 | 0.19 |
| EPS Basic Continuous Ops | 0.54 | 0.23 | 0.27 | 0.18 | 0.19 |
| EPS Diluted Total Ops | 0.54 | 0.23 | 0.27 | 0.19 | 0.19 |
| EPS Diluted Continuous Ops | 0.54 | 0.23 | 0.27 | 0.18 | 0.19 |
| EPS Diluted Before Non-Recurring Items | 0.56 | 0.38 | 0.40 | 0.18 | 0.19 |
| EBITDA(a) | $20,039 | $9,261 | $-30 | $21,006 | $8,912 |